Stocks
Terumo CorporationTRUMY
OTCHealthcareMedical Devices$12.90+1.34%
Price as of · delayed, not real-time
A leading global medical device manufacturer specializing in products for blood transfusion, cardiovascular systems, and diabetes care. The company is widely recognized for its innovation in healthcare solutions and maintains a strong presence in both developed and emerging markets. Investors monitor its performance due to its consistent growth and strategic expansion in the medical technology sector.
Market Cap: $19.0B52W Range: $12.15 – $20.12
Congressional Interest in Terumo Corporation (TRUMY)
2 members of Congress have disclosed 4 trades in Terumo Corporation (TRUMY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
2
Buys
1
Sells
3
Who in Congress Is Trading TRUMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-31 | Daniel Goldman | buy | $1K – $15K |
| 2023-02-27 | Daniel Goldman | sell | $15K – $50K |
| 2017-08-17 | JAMES B. RENACCI | sell | $1K – $15K |